Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
451.20    -11.40 (-2.46%)
Bid:
451.00
Ask:
451.80
Spread: 0.80 (0.177%)
Market Cap: £2.32b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

£80m contract win with UK MOD

16 Jan 2023 07:00

RNS Number : 7531M
QinetiQ Group plc
16 January 2023
 

News release

QinetiQ Group Plc

£80m contract win with UK MOD

16 January 2023 - QinetiQ Group plc ("QinetiQ" or the "Company") is pleased to announce that it has won an £80m contract with the UK's Ministry of Defence (MOD).  The contract will provide expertise, training and support to accelerate and transform mission data production; this will enable military platforms and personnel, from the UK and its allies, to be better protected in a rapidly changing threat landscape and enhance the performance of our advanced military systems.

 

We will work in partnership with the MOD for a 10-year period on the transformation project, providing a specialist mission data and electronic warfare skills solution alongside training and IT support. This win is a great example of our cyber and information advantage distinctive offering and the strength of our partnering across industry, bringing together extensive experience of electronic warfare, mission data analysis, communication and information services and data-led transformation to achieve operational advantage over our adversaries.

 

James Willis, Chief Executive of UK Intelligence at QinetiQ said:

 

"We are delighted to be selected as the MoD's Industry Partner for mission data. The contract demonstrates how the MoD works closely with industry to build the skills of the future and introduce innovative approaches to enhance mission capability. Our team is harnessing the value delivered by small and medium sized companies and our academic partners. We look forward to working together in partnership with the MoD delivering the next generation of mission data."

 

About QinetiQ

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence and security markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

John Haworth, Group Head of Investor Relations:

+44 (0) 7920 545841

Lorna Cobbett, Citigate Dewe Rogerson (Media enquiries):

+44 (0) 7771 344781

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTDBGDBGXBDGXU
Date   Source Headline
23rd Nov 202212:16 pmRNSCompletion of the acquisition of Avantus
10th Nov 202212:13 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSSecond Quarter Trading Update
11th Oct 20223:28 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:06 amRNSAcquisition of Air Affairs & disposal of Space NV
12th Sep 20223:28 pmRNSDirector/PDMR Shareholding
26th Aug 202212:53 pmRNSDirector/PDMR Shareholding
10th Aug 20223:36 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSDelivering growth in the US with $45m contract win
5th Aug 20226:22 pmRNSProposed Acquisition of Avantus Federal LLC
1st Aug 20223:19 pmRNSHolding(s) in Company
21st Jul 20223:18 pmRNSResult of AGM
21st Jul 20227:00 amRNSFirst Quarter Trading Update
19th Jul 20225:24 pmRNSHolding(s) in Company
12th Jul 20222:09 pmRNSHolding(s) in Company
12th Jul 20221:47 pmRNSDirector/PDMR Shareholding
29th Jun 20225:09 pmRNSDirector/PDMR Shareholding
27th Jun 202212:35 pmRNSHolding(s) in Company
15th Jun 20229:53 amRNSHolding(s) in Company
13th Jun 202212:59 pmRNSDirector/PDMR Shareholding
13th Jun 202212:28 pmRNSAnnual Financial Report
6th Jun 202210:52 amRNSHolding(s) in Company
30th May 202212:03 pmRNSNotification of Major Shareholding
23rd May 20227:00 amRNSConfirmation of Full Year Results
19th May 20227:00 amRNSPreliminary Results
18th May 20227:00 amRNSDirectorate Change
17th May 202211:24 amRNSHolding(s) in Company
16th May 20221:45 pmRNSHolding(s) in Company
10th May 202211:49 amRNSDirector/PDMR Shareholding
27th Apr 20227:00 amRNSInvestor Seminar: Delivering our global ambition
26th Apr 20221:37 pmRNSHolding(s) in Company
21st Apr 20229:15 amRNSHolding(s) in Company
20th Apr 20227:00 amRNSFourth Quarter Trading Update
12th Apr 202212:45 pmRNSDirector/PDMR Shareholding
10th Mar 202211:27 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
2nd Feb 20228:42 amRNSHolding(s) in Company
24th Jan 202211:12 amRNSDirector/PDMR Shareholding
19th Jan 20221:43 pmRNSHolding(s) in Company
18th Jan 20227:00 amRNSThird Quarter Trading Update
17th Jan 20227:00 amRNSAppointment of President and CEO of QinetiQ US
11th Jan 202211:43 amRNSDirector/PDMR Shareholding
5th Jan 20225:05 pmRNSDirector/PDMR Shareholding
20th Dec 20219:21 amRNSDirector Declaration
10th Dec 202112:42 pmRNSDirector/PDMR Shareholding
6th Dec 202112:16 pmRNSHolding(s) in Company
18th Nov 202111:04 amRNSDirector/PDMR Shareholding
17th Nov 202110:54 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.